Form 8-K - Current report:
SEC Accession No. 0001437749-24-030269
Filing Date
2024-09-30
Accepted
2024-09-30 17:11:00
Documents
16
Period of Report
2024-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20240928c_8k.htm   iXBRL 8-K 35828
2 EXHIBIT 4.1 ex_728234.htm EX-4.1 118346
3 EXHIBIT 10.1 ex_728235.htm EX-10.1 32291
  Complete submission text file 0001437749-24-030269.txt   364926

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240930.xsd EX-101.SCH 3943
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240930_def.xml EX-101.DEF 13521
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240930_lab.xml EX-101.LAB 17826
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240930_pre.xml EX-101.PRE 13498
18 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240928c_8k_htm.xml XML 4962
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 241340344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)